Crosstalk between Estrogen Signaling and Breast Cancer Metabolism

Eylem Kulkoyluoglu-Cotul, Alexandra Arca, Zeynep Madak-Erdogan

Research output: Contribution to journalReview article

Abstract

Estrogens and estrogen receptors (ERs) regulate metabolism in both normal physiology and in disease. The metabolic characteristics of intrinsic breast cancer subtypes change based on their ER expression. Crosstalk between estrogen signaling elements and several key metabolic regulators alters metabolism in breast cancer cells, and enables tumors to rewire their metabolism to adapt to poor perfusion, transient nutrient deprivation, and increased acidity. This leads to the selection of drug-resistant and metastatic clones. In this review we discuss studies revealing the role of estrogen signaling elements in drug resistance development and metabolic adaptation during breast cancer progression.

Original languageEnglish (US)
Pages (from-to)25-38
Number of pages14
JournalTrends in Endocrinology and Metabolism
Volume30
Issue number1
DOIs
StatePublished - Jan 2019

Fingerprint

Estrogens
Breast Neoplasms
Estrogen Receptors
Drug Resistance
Clone Cells
Perfusion
Food
Pharmaceutical Preparations
Neoplasms

Keywords

  • breast cancer
  • cancer metabolism
  • drug resistance
  • estrogen signaling
  • metabolic regulators
  • nutrient availability

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Crosstalk between Estrogen Signaling and Breast Cancer Metabolism. / Kulkoyluoglu-Cotul, Eylem; Arca, Alexandra; Madak-Erdogan, Zeynep.

In: Trends in Endocrinology and Metabolism, Vol. 30, No. 1, 01.2019, p. 25-38.

Research output: Contribution to journalReview article

Kulkoyluoglu-Cotul, Eylem ; Arca, Alexandra ; Madak-Erdogan, Zeynep. / Crosstalk between Estrogen Signaling and Breast Cancer Metabolism. In: Trends in Endocrinology and Metabolism. 2019 ; Vol. 30, No. 1. pp. 25-38.
@article{62b8b2c5899540fb8c8e6611d09bc296,
title = "Crosstalk between Estrogen Signaling and Breast Cancer Metabolism",
abstract = "Estrogens and estrogen receptors (ERs) regulate metabolism in both normal physiology and in disease. The metabolic characteristics of intrinsic breast cancer subtypes change based on their ER expression. Crosstalk between estrogen signaling elements and several key metabolic regulators alters metabolism in breast cancer cells, and enables tumors to rewire their metabolism to adapt to poor perfusion, transient nutrient deprivation, and increased acidity. This leads to the selection of drug-resistant and metastatic clones. In this review we discuss studies revealing the role of estrogen signaling elements in drug resistance development and metabolic adaptation during breast cancer progression.",
keywords = "breast cancer, cancer metabolism, drug resistance, estrogen signaling, metabolic regulators, nutrient availability",
author = "Eylem Kulkoyluoglu-Cotul and Alexandra Arca and Zeynep Madak-Erdogan",
year = "2019",
month = "1",
doi = "10.1016/j.tem.2018.10.006",
language = "English (US)",
volume = "30",
pages = "25--38",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Crosstalk between Estrogen Signaling and Breast Cancer Metabolism

AU - Kulkoyluoglu-Cotul, Eylem

AU - Arca, Alexandra

AU - Madak-Erdogan, Zeynep

PY - 2019/1

Y1 - 2019/1

N2 - Estrogens and estrogen receptors (ERs) regulate metabolism in both normal physiology and in disease. The metabolic characteristics of intrinsic breast cancer subtypes change based on their ER expression. Crosstalk between estrogen signaling elements and several key metabolic regulators alters metabolism in breast cancer cells, and enables tumors to rewire their metabolism to adapt to poor perfusion, transient nutrient deprivation, and increased acidity. This leads to the selection of drug-resistant and metastatic clones. In this review we discuss studies revealing the role of estrogen signaling elements in drug resistance development and metabolic adaptation during breast cancer progression.

AB - Estrogens and estrogen receptors (ERs) regulate metabolism in both normal physiology and in disease. The metabolic characteristics of intrinsic breast cancer subtypes change based on their ER expression. Crosstalk between estrogen signaling elements and several key metabolic regulators alters metabolism in breast cancer cells, and enables tumors to rewire their metabolism to adapt to poor perfusion, transient nutrient deprivation, and increased acidity. This leads to the selection of drug-resistant and metastatic clones. In this review we discuss studies revealing the role of estrogen signaling elements in drug resistance development and metabolic adaptation during breast cancer progression.

KW - breast cancer

KW - cancer metabolism

KW - drug resistance

KW - estrogen signaling

KW - metabolic regulators

KW - nutrient availability

UR - http://www.scopus.com/inward/record.url?scp=85056822346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056822346&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2018.10.006

DO - 10.1016/j.tem.2018.10.006

M3 - Review article

C2 - 30471920

AN - SCOPUS:85056822346

VL - 30

SP - 25

EP - 38

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 1

ER -